Zepp Health's business model is evolving from a commoditized OEM supplier to a brand-centric wearable technology company with integrated AI and ecosystem services. This shift supports improved margins and differentiation, as reflected in recent margin expansion and product launches. Growth sustaina…
Zepp Health (ZEPP) Q1 2025: Amazfit Brand Sales Rise 10.2% Amid Supply Chain Resilience and AI Innovation
Zepp Health's first quarter 2025 marks a return to growth for its core Amazfit brand, driven by new product launches and supply chain diversification. Despite seasonality and ongoing supply constraints, strategic AI integration and global marketing partnerships underpin a confident outlook for accelerated expansion. Management projects a strong second quarter with revenue growth of up to 35% year-over-year, signaling a pivotal inflection in the company’s brand-driven transformation.
Summary
- Brand Resurgence: Amazfit-branded products achieved notable sales growth, reversing a multi-year decline.
- Supply Chain Adaptation: Dual-sourcing between China and Vietnam mitigated tariff impacts and enhanced operational resilience.
- AI-Enabled Differentiation: Advanced AI features and ecosystem services are expanding user engagement and competitive positioning.
Business Overview
Zepp Health Corporation is a global leader in smart wearable devices and health technology, generating revenue primarily through its consumer brands, including Amazfit, Zepp Clarity, and Zepp Aura. The company operates a vertically integrated model combining proprietary hardware, software (Zepp OS), and AI-driven health services, with sales spread across over 90 countries. Its business segments focus on wearable devices, AI-powered health solutions, and ecosystem services that collectively support fitness and wellness management.
Performance Analysis
In the first quarter of 2025, Zepp Health reported revenues of approximately $39 million, reflecting a slight decline of 3.6% year-over-year, primarily due to a $5 million decrease in Xiaomi wearable product sales. However, this was offset by a 10.2% increase in Amazfit-branded product sales, marking the first year-over-year growth since early 2022 and signaling a successful turnaround of its core brand portfolio. This growth was fueled by the launches of the Amazfit Active 2 and Bip 6 smartwatches, with sales momentum expected to accelerate as supply constraints ease.
The company’s gross margin improved to 37.3%, up from 36.8% a year earlier, despite facing additional tariff pressures on China-made goods. Excluding tariffs, the margin would have been 38.4%, reflecting the higher profitability of new product introductions. Operating expenses rose modestly to $32.7 million, driven by increased marketing investments and channel development, but research and development expenses were managed down by 7.8% year-over-year due to refined resource allocation. The net loss widened to $19.7 million, consistent with seasonal trends and ongoing investments in growth initiatives.
- Margin Expansion Despite Tariffs: New product mix and supply chain strategies helped sustain gross margin improvement.
- Marketing and Channel Investment: Increased spending on digital campaigns and retail channel optimization supported brand visibility.
- Cost Discipline in R&D: Focused innovation efforts maintained competitive edge while reducing expenses.
Overall, the financial results reflect a company navigating a seasonal low while positioning for growth, with operational improvements and product launches driving optimism for the remainder of the year.
Executive Commentary
"In the first quarter of 2025, we are happy to see that our Amazfit revenue grew 10% year over year as we execute against a difficult macro backdrop while sharpening our operating model for long-term resilience. Tariff relief on key smartwatch categories in the United States and our dual-sourcing strategy between China and Vietnam helped cushion some external cost pressures, and the additional Vietnam capacity we brought online further de-risked the supply chain."
Wayne Huang, Chairman and CEO
"Our results in the first quarter of 2025 tracked closely with guidance. We are pleased to report that Amazfit products revenue has returned to growth after a two-year transformation period. This marks a significant milestone in our ongoing strategy toward a more brand-driven growth model. The strong performance reflects continued momentum in our core markets and the successful launches of key products, which have outperformed prior models in terms of sales velocity and market reception."
Leon Deng, CFO
Strategic Positioning
1. Brand-Driven Growth Model
Zepp Health is transitioning from an OEM/ODM manufacturer to a brand-centric company, focusing on Amazfit as the primary growth engine. This strategy aims to elevate margins and profitability by expanding self-branded product sales that cover operating expenses and establish a sustainable competitive position akin to Garmin.
2. Supply Chain Diversification and Tariff Mitigation
Proactively establishing dual manufacturing bases in China and Vietnam has allowed Zepp Health to circumvent new US tariffs on Chinese imports. Approximately 20-25% of products sold in the US are now sourced outside China, insulating the company from tariff impacts and supply disruption risks.
3. AI Integration and Ecosystem Expansion
Zepp Health is embedding AI technologies such as OpenAI and Google Gemini into its wearables and app services, enhancing user experience with features like rapid voice command responsiveness and cost-efficient food recognition. The launch of AI-powered nutrition devices and expanded food logging services in Europe and North America exemplifies this ecosystem approach, aiming to deepen user engagement and subscription revenue potential.
4. Product Portfolio Segmentation
The company’s product roadmap covers multiple price tiers: entry-level (Active 2 and Bip 6), mid-level (Balance series), and premium (T-Rex series). This segmentation supports broadening the user base while targeting higher-margin segments with advanced features, driving both volume and profitability.
5. Strategic Marketing and Partnerships
Zepp Health is leveraging partnerships with global athletes and sports organizations like HYROX to enhance brand visibility and credibility. These collaborations, combined with increased offline retail presence in key markets, are designed to accelerate sales growth and strengthen the brand’s position in competitive markets.
Key Considerations
The first quarter results underscore the importance of product innovation, supply chain agility, and brand-building in Zepp Health’s ongoing transformation.
Key Considerations:
- Seasonality Impact: Q1 traditionally represents the lowest sales period in consumer electronics, limiting margin leverage despite growth in core products.
- Supply Constraints: Premium product availability, particularly the Active 2 premium version, remains a bottleneck but is expected to resolve in Q2.
- Shift from Xiaomi Dependency: Declining Xiaomi-related revenues reflect strategic focus on self-branded growth and margin improvement.
- Marketing Efficiency: Increased marketing spend is targeted and measured, balancing brand expansion with cost discipline.
- Debt Refinancing and Cash Management: Successful refinancing to longer-term debt and improved working capital management enhance financial flexibility.
Risks
Zepp Health faces risks from global macroeconomic uncertainty, potential supply chain disruptions, and competitive pressures in the wearable market. The company’s reliance on new product launches to sustain growth introduces execution risk, while tariff policies and foreign exchange fluctuations remain potential margin headwinds. Management’s optimistic guidance assumes resolution of supply constraints and sustained consumer demand, which could be challenged by external factors.
Forward Outlook
For the second quarter of 2025, Zepp Health projects revenues between $50 million and $55 million, representing 23% to 35% growth year-over-year. Management anticipates continued growth in Amazfit-branded sales driven by new product launches and easing supply constraints. Operating expenses are expected to be managed within a range of $25 million to $27 million, reflecting ongoing investments in R&D and marketing balanced with cost control initiatives.
Takeaways
Zepp Health’s Q1 2025 results highlight a critical inflection point in its brand-led transformation, with new product momentum and supply chain resilience driving renewed growth.
- Brand Growth Momentum: The 10.2% year-over-year increase in Amazfit sales confirms the success of recent product launches and validates the strategic shift away from OEM reliance.
- Operational Resilience: Dual-sourcing and tariff mitigation strategies have effectively insulated margins, providing a competitive advantage amid geopolitical uncertainties.
- AI and Ecosystem Differentiation: Advanced AI features and health-focused ecosystem services position Zepp Health to capitalize on emerging consumer trends and expand recurring revenue streams.
Conclusion
Zepp Health’s first quarter 2025 results demonstrate tangible progress in its strategic pivot toward a self-branded, AI-enhanced wearable ecosystem. While seasonal and supply challenges persist, the company’s diversified product portfolio, supply chain agility, and marketing initiatives provide a solid foundation for accelerated growth and margin improvement in 2025.
Industry Read-Through
Zepp Health’s experience reflects broader industry dynamics where brand differentiation, AI integration, and supply chain diversification are becoming critical competitive levers amid a contracting global smartwatch market. The shift away from commoditized OEM models toward proprietary branded ecosystems mirrors trends seen with other mid-tier players seeking to challenge incumbents like Apple and Garmin. Additionally, Zepp Health’s tariff mitigation strategies and AI-powered health service expansions offer a blueprint for peers navigating geopolitical headwinds and evolving consumer expectations in wearable technology.